Arie Belldegrun, Chairman, President and CEO at Kite Pharma, Inc. (KITE), sold 52,694 shares at $179.66 ($9.5M) on 2017-09-25, disclosed to the SEC on 2017-09-27.
Open-market sale of $9.5M KITE by Chairman, President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $179.66 | 26,347 | $4.7M | 50.0% |
| 2 | $179.66 | 26,347 | $4.7M | 50.0% |
| Total | $179.66 avg | 52,694 | $9.5M | 100% |
| Filing → |
| ALLO | BUY | 2020-06-04 | $6.9M | — | Filing → |
| ALLO | BUY | 2019-02-13 | $3.5M | — | Filing → |
| KITE | BUY | 2017-05-09 | $1.2M | — | Filing → |